![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C07D 223/16 | (2006.01) |
C07D 223/16 | (2013.01) | ||
C07D 223/32 | (2006.01) | ||
C07D 223/32 | (2013.01) | ||
C07D 491/052 | (2006.01) | ||
C07D 491/052 | (2013.01) | ||
A61K 31/55 | (2006.01) | ||
A61P 25/32 | (2018.01) | ||
A61P 3/04 | (2006.01) | ||
A61P 3/04 | (2018.01) | ||
A61P 3/10 | (2018.01) | ||
A61P 25/08 | (2018.01) | ||
A61K 31/55 | (2013.01) |
(11) | Patento numeris | 3328835 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 16751083.3 |
Europos patento paraiškos padavimo data | 2016-07-28 | |
(97) | Europos patento paraiškos paskelbimo data | 2018-06-06 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2022-10-12 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2016/044426 |
Data | 2016-07-28 |
(87) | Numeris | WO 2017/023679 |
Data | 2017-02-09 |
(30) | Numeris | Data | Šalis |
201562199382 P | 2015-07-31 | US |
(72) |
LEHMANN, Juerg , US
FEICHTINGER, Konrad , US
REN, Albert S. , US
SEMPLE, Graeme , US
|
(73) |
Arena Pharmaceuticals, Inc. ,
235 East 42nd Street, New York, NY 10017,
US
|
(54) | 5-HT2C RECEPTOR AGONISTS AND COMPOSITIONS AND METHODS OF USE |
5-HT2C RECEPTOR AGONISTS AND COMPOSITIONS AND METHODS OF USE |